Characterization of hypervariable region in hepatitis C virus envelope protein during acute and chronic infection

Archives of Virology

Volumn 150, Issue 5, 2005, Pages 883-898

  Higashi, K ^a,b   Tsukiyama Kohara, K ^a   Tanaka, T ^c   Tanaka, E ^d   Kiyosawa, K ^d   Kohara, M ^a  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b SYSMEX CORPORATION   (Japan)

^c TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^d SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

E1 PROTEIN, HEPATITIS C VIRUS; GLYCOPROTEIN E2, HEPATITIS C VIRUS; HVR1 PROTEIN, HEPATITIS C VIRUS; VIRUS ENVELOPE PROTEIN; VIRUS PROTEIN;

ACUTE DISEASE; ADULT; AGED; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; CHEMISTRY; CHRONIC DISEASE; CLASSIFICATION; DNA SEQUENCE; FEMALE; GENETIC VARIABILITY; GENETICS; GENOTYPE; HEPATITIS C VIRUS; HUMAN; MALE; MIDDLE AGED; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOGENICITY;

ACUTE DISEASE; ADULT; AGED; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; BASE SEQUENCE; CHRONIC DISEASE; FEMALE; GENOTYPE; HEPACIVIRUS; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; SEQUENCE ANALYSIS, DNA; VARIATION (GENETICS); VIRAL ENVELOPE PROTEINS; VIRAL PROTEINS;

HEPATITIS C VIRUS;

EID: 17644417856     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-004-0470-0     Document Type: Article

References (30)

1. Abrignani S (1997) Immune responses throughout hepatitis C virus (HCV) infection: HCV from the immune system point of view. Springer Semin Immunopathol 19: 47-55
2. Agnello V, Abel G, Elfahal M, Knight GB, Zhang Q-X (1999) Hepatitis C virus and other Flaviviridae viruses enter cells via low density lipoprotein receptor. Proc Natl Acad Sci USA 96: 12766-12771
3. Alter MJ, Margolis HS, Krawczynski K, Judson FN, Mares A, Alexander WJ, Hu PY, Miller JK, Gerber MA, Sampliner RE, Meeks E, Beach MJ (1992) The natural history of community acquired hepatitis C in the United States. N Engl J Med 327: 1899-1905
4. Chomczynski P, Sacchi N (1987) Single step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159
5. Crotta S, Stilla A, Wack A, D'Andrea A, Nuri S, D'Oro U, Mosca M, Filliponi F, Brunetto RM, Bonino F, Abrignani S, Nicholas MV (2002) Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein. J Exp Med 195: 35-41
6. Farci PA, Shimoda A, Wong D, Cabezon D, De Gioannis D, Strazzera A, Shimizu Y, Shapiro M, Alter HJ, Purcell RH (1996) Prevention of hepatitis C virus infection in chimpanzee by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein. Proc Natl Acad Sci USA 93: 15394-15399
7. Farci P, Bukh J, Purcell RH (1997) The quasispecies of hepatitis C virus and the host immune response. Springer Semin Immunopathol 19: 5-26
8. Farci P, Shimoda A, Coiana A, Diaz G, Peddis G, Melpolder JC, Strazzera A, Chien DY, Munoz SJ, Balestrieri A, Purcell RH, Alter HJ (2000) The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science 288: 339-344
9. Higashi Y, Kakumu S, Yoshioka K, Wakita T, Mizokami M, Ohba K, Itoh Y, Ishikawa T, Takegami M, Nagai Y (1993) Dynamics of genome change in the E2/NS1 region of hepatitis C virus in vivo. Virology 197: 659-668
10. Itakura J, Nagayama K, Enomoto N, Sakamoto N, Tazawa J, Izumi N, Marumo F, Sato C (2001) CD81 nucleotide mutation in hepatocellular carcinoma and lack of CD81 polymorphism in patients at stages of hepatitis C virus infection. J Med Virol 63: 22-28
11. Garcia JE, Puentes A, Suarez J, Lopez R, Vera R, Rodriguez LE, Ocampo M, Curtidor H, Guzman F, Urquiza M, Patarroyo ME (2002) Hepatitis C virus (HCV) E1 and E2 proteins that specifically bind to HepG2 cells. J Hepatol 36: 254-262
12. Kao JH, Chen P-J, Lai M-J, Wang TH, Chen DS (1995) Quasispecies of hepatitis C virus and genetic drift of the hypervariable region in chronic type C hepatitis. J Infect Dis 172: 261-264
13. Kato N, Sekiya H, Ootsuyama Y, Nakazawa T, Hijikata M, Ohkoshi S, Shimotohno K (1993) Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus. J Virol 67: 3923-3930
14. Kato N, Ootsuyama Y, Sekiya H, Ohkoshi S, Nakazawa T, Hijikata M, Shimotohno K (1994) Genetic drift in hypervariable region 1 of the viral genome in persistent hepatitis C virus infection. J Virol 68: 4776-4784
15. Lanford RE, Chavez D, Chsari FV, Sureau C (1995) Lack of detection of negative-strand hepatitis C virus RNA in peripheral blood mononuclear cells and other extrahepatic tissues by the highly strand-specific rTth reverse transcriptase PCR. J Virol 69: 8079-8083
16. Lawa Z, Petrick J, Wong V-S, Alexander GJM, Allain JP (1997) Hepatitis C virus genomic variability in untreated and immunocompromised patients. Virology 228: 107-111
17. Levy S, Todd S, Maecker H (1998) CD81 (TAPA-1): a molecule involved in signal transduction and cell adhesion in the immune system. Annu Rev Immunol 16: 89-109
18. Monazahian M, Bohme I, Bonk S, Koch A, Scholz C, Grethe S, Thomssen R (1999) Low density lipoprotein receptor as a candidate receptor for hepatitis C virus. J Med Virol 57: 223-229
19. Nakatsuji Y, Matsumoto A, Tanaka E, Ogata H, Kiyosawa K (1992) Detection of chronic hepatitis C virus infection by four diagnostic systems: first-generation and second-generation enzyme-linked immunosorbent assay, second-generation recombinant immunoblot assay and nested polymerase chain reaction analysis. Hepatology 16: 300-305
20. Odeberg J, Yun Z, Sonnerborg K, Bijoro K, Uhlen M, Lundberg J (1997) Variation of hepatitis C hypervariable region 1 in immunocompromised patients. J Infect Dis 175: 938-943
21. Okada S, Akahane Y, Suzuki H, Okamoto H, Mishiro S (1992) The degree of variability in the amino acid terminal region of the E2/NS1 protein of hepatitis C virus correlates with responsiveness to interferon therapy in viremic patients. Hepatology 16: 619-624
22. Okamoto H, Kojima M, Okada S, Yoshizawa H, Iizuka H, Tanaka T, Munchmre E, Peterson DA, Ito Y, Mishiro S (1992) Genetic drift of hepatitis C virus during an 8.2-year infection in a chimpanzee: variability and stability. Virology 190: 894-899
23. Pileri P, Uematsu Y, Campagnoli S, Galli G, Falugi F, Petracca R, AJ W, Houghton M, Rosa D, Grandi G, Abrignani S (1998) Binding of hepatitis C virus to CD81. Science 282: 938-941
24. Rice CM (1996) Flaviviridae: The viruses and their replication. In: Fields BN, Kniee DN, Howley PM (eds), Fields virology. Lippincott Raven Publ, Philadelphia, PA, pp 931-959
25. Saito I, Miyamura T, Ohbayashi A, Harada H, Katayama T, Kikuchi S, Watanabe Y, Koi S, Onji M, Ohta Y, Choo Q, Houghton M, Kuo G (1990) Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci USA 87: 6547-6549
26. Saitou N, Nei M (1987) The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 4: 406-425
27. Sanger F, Nicklen S, Coulson AR (1977) DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74: 5463-5467
28. Weiner AJ, Brauer MJ, Rosenblat J, Rivhman KH, Tung J, Crawford K, Bonino F, Saracco G, Choo Q-L, Houghton M, Han JH (1991) Variable and hypervariable domains are found in the regions of HCV corresponding to the Flavivirus envelope and NSl proteins and the pestivirus envelope glycoproteins. Virology 180: 842-848
29. Yamaguchi K, Tanaka E, Higashi K, Kiyosawa K, Matsumoto A, Furuta S, Hasegawa A, Tanaka S, Kohara M (1994) Adaptation of hepatitis C virus for persistent infection in patients with acute hepatitis. Gastroenterology 106: 1344-1348
30. Yoshioka K, Kakumu S, Wakita T, Ishikawa T, Itoh Y, Takayanagi M, Higashi Y, Shibata M, Morishima T (1992) Detection of hepatitis C virus by polymerase chain reaction and response to interferon α therapy: relationship to genotypes of hepatitis C virus. Hepatology 16: 293-299